EG17529A - Improved formulation of antiinflammatory drugs - Google Patents

Improved formulation of antiinflammatory drugs

Info

Publication number
EG17529A
EG17529A EG648/85A EG64885A EG17529A EG 17529 A EG17529 A EG 17529A EG 648/85 A EG648/85 A EG 648/85A EG 64885 A EG64885 A EG 64885A EG 17529 A EG17529 A EG 17529A
Authority
EG
Egypt
Prior art keywords
guanidino
imidazolyl
thiazole
methyl
antiinflammatory drugs
Prior art date
Application number
EG648/85A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG17529A publication Critical patent/EG17529A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
EG648/85A 1984-10-11 1985-10-10 Improved formulation of antiinflammatory drugs EG17529A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65975284A 1984-10-11 1984-10-11
US06/765,415 US4636498A (en) 1984-10-11 1985-08-15 Formulation of antiinflammatory drugs

Publications (1)

Publication Number Publication Date
EG17529A true EG17529A (en) 1993-08-30

Family

ID=27097890

Family Applications (1)

Application Number Title Priority Date Filing Date
EG648/85A EG17529A (en) 1984-10-11 1985-10-10 Improved formulation of antiinflammatory drugs

Country Status (16)

Country Link
US (1) US4636498A (fi)
EP (1) EP0178121B1 (fi)
CN (1) CN1011196B (fi)
AT (1) ATE53492T1 (fi)
AU (1) AU558668B2 (fi)
CA (1) CA1251138A (fi)
DE (1) DE3578125D1 (fi)
DK (1) DK165964C (fi)
EG (1) EG17529A (fi)
FI (1) FI853948L (fi)
GR (1) GR852459B (fi)
IE (1) IE58740B1 (fi)
IL (1) IL76647A0 (fi)
NZ (1) NZ213756A (fi)
PH (1) PH21400A (fi)
PT (1) PT81280B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
NZ230701A (en) * 1988-09-20 1992-01-29 Glaxo Group Ltd Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate
EP0703782A1 (en) * 1993-06-15 1996-04-03 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715112A (fi) * 1966-11-21 1968-05-22
US4230717A (en) * 1978-12-29 1980-10-28 Lovelace Alan M Administrator Indomethacin-antihistamine combination for gastric ulceration control
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
DK463885D0 (da) 1985-10-10
IL76647A0 (en) 1986-02-28
AU558668B2 (en) 1987-02-05
PT81280A (en) 1985-11-01
CA1251138A (en) 1989-03-14
CN1011196B (zh) 1991-01-16
FI853948L (fi) 1986-04-12
PT81280B (pt) 1988-02-17
US4636498A (en) 1987-01-13
PH21400A (en) 1987-10-15
DK463885A (da) 1986-04-12
FI853948A0 (fi) 1985-10-10
DE3578125D1 (de) 1990-07-19
GR852459B (fi) 1986-02-11
EP0178121B1 (en) 1990-06-13
EP0178121A3 (en) 1988-10-05
DK165964C (da) 1993-07-26
DK165964B (da) 1993-02-22
IE58740B1 (en) 1993-11-03
EP0178121A2 (en) 1986-04-16
IE852494L (en) 1987-02-15
AU4848585A (en) 1986-05-08
ATE53492T1 (de) 1990-06-15
CN85107521A (zh) 1986-08-06
NZ213756A (en) 1988-11-29

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
BR1100546A (pt) Compostos e composições de piridil imidazol.
ES8700666A1 (es) Procedimiento para la preparacion de derivados de 2-(piridi-lalquilenosulfinil)benzimidazoles n-substituidos como agen- tes antisecretorios gastricos
WO1991019475A1 (en) Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d¿4?
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
IT1214671B (it) Metodo per inibire l'insorgere di sindrome da radiazioni e composizione diendotossina detossificata impiegata a tale scopo
EG17529A (en) Improved formulation of antiinflammatory drugs
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
JPS6434967A (en) Heterocyclic compound, manufacture and pharmaceutical or veterinary composition having aromatase inhibition
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
IT1233763B (it) Metodo per ottenere composti polverulenti altofondenti inorganici e composizioni metalliche.
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
GR3023427T3 (en) Heteroarylmethylbenzols aromatase inhibitors
DK158738C (da) 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater og laegemiddel indeholdende saadanne forbindelser
AU4461496A (en) The use of heterocyclic compounds as antioxidants, radical scavengers, fe2+ complexing agents, tissue- and/or neuroprotectants
NO885640D0 (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
FR2693368B1 (fr) Trépan perfectionné notamment pour chirurgie oculaire.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
EP0811620A4 (en) PHENYLAMIDINOTHIOPHENE DERIVATIVES AND ANTIPHLOGISTIC AGENT CONTAINING THEM
IT8920994A0 (it) Nuovi derivati imidazolici ad azione inibente l'enzima trombossanosintetasi.
GEP20022655B (en) Substituted Nitrogen Containing Heterocycles as Inhibitors of p38 Protein Kinase
IT8721356A0 (it) Composizioni atte ad aumentare la crescita di animali, e composti relativi.
IT8721299A0 (it) Procedimento per l'idrofobizzazione di oggetti di gesso.